Form D · Biotechnology
Bone Health Technologies, Inc.
Redwood City, CA · CIK 0001785502
Offering snapshot reported May 9, 2023 · SEC filing
- Reported sold
- $3.16M Offering amount: $4.16M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 18, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 9, 2023 | Initial | $3,157,086 | No comparison | 22 | SEC filing |
| Aug 15, 2019 | Initial | $504,999 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-481217
Source: Form D, filed May 9, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kian Beyzavi | Director |
| Daniel Burnett | Director, Executive |
| Sam Goldberger | Director |
| Marcie Hamilton | Director |
| Michael Jaasma | Director |
| Shane Mangrum | Director |
| John Osborne | Director |
| Pamela Peeke | Director |
| Laura Yecies | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
370 Convention Way
Redwood City, CA, 94063
Redwood City, CA, 94063